University of Vermont

College of Medicine

Currently Recruiting - Learn More About Becoming a Volunteer >>

A Phase 1 Study of the Safety and Immunogenicity of a 2-Dose Regimen of West Nile/Denge 4-3' Δ30 Chimeric Virus Vaccine, a Live Attenuated Vaccine for West Nile Encephalitis, in Flavivirus-Naive Adults 50-65 Years of Age.

 

Vaccine Testing Center

Improving global health

Our faculty researchers study new human vaccines with the ultimate goal of understanding and preventing infectious diseases across the globe. We are particularly interested in new vaccines which hope to prevent or control infectious diseases in developing countries. Our group consists of a diverse team of clinicians, study coordinators, scientists, laboratory personnel, and volunteers. Our human research studies are carefully designed and are performed with rigorous oversight and in the safest possible manner. All studies are approved by the ethics review board (Institutional Review Board, IRB) of the University of Vermont.

 

Volunteer

Volunteers are central to the mission of the Vaccine Testing Center. We are currently recruiting healthy adults for both inpatient and outpatient vaccine trials. Compensation is available to qualified volunteers. Click here for more information.

Research

Our team runs a fully functioning unit for performing phase I and II vaccine trials and enteric challenge models at the Vaccine Testing Center (VTC). In general, the VTC focuses on the development of vaccines of importance to global health, including typhoid fever, Campylobacter infections and dengue viral diseases.

Recent News

Dr. Chad Mitchell Joins the VTC

Dr. Kirkpatrick named ELAM Fellow

Drs. Kirkpatrick and Pierce publish new Dengue research

 

Last modified December 18 2013 03:19 PM